BlackRock Financial Institutions Series Trust lists 0.42% annual operating expenses after fee waivers for Investor A and Institutional shares in BlackRock Summit Cash Reserves Fund.
The move will shift allAssetsand liabilities to the acquiring fund, while shareholders receive shares with value equal to their holdings’ aggregate net asset value immediately before completion.
Telemachus Therapeutics, Inc. is offering $1,500,000 in an exempt securities offering, with $125,000 already sold. The notice lists $1,375,000 as the unsold portion. The securities are structured as a Simple Agreement for Future Equity, or SAFE.
L3Harris Technologies, Inc. (NYSE: LHX) awarded Christopher T. Aebli 5,692 derivative securities on 1 September 2026. Aebli is the company’s president of Comm & Spect. Dominance. His reported holdings after the transaction totaled 5,692 derivative securities.
URBAN ONE, INC. (NASDAQ: UONEK) saw Co-President of the Audio Division Levingston Lemuel Deon sell 5,646 shares at $4.15 per share. The transaction took place on Aug. 31, 2026, and left Deon with 1,600 shares.
ACCURAY INC (NASDAQ: ARAY) has beneficial ownership tied to The TCW Group at 18.7%, with 27,527,916 common shares issuable upon warrant exercise included in the calculation. The position is held on behalf of the TCWBusinessUnit.
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) awarded Chief Commercial Officer Margaret Ekins 1,001,738 derivative securities. The transaction leaves Ekins with ownership of 1,001,738 derivative securities, matching the amount awarded.
Decoy Therapeutics Inc. (NASDAQ: DCOY) awarded Gauthier Patricia G. 2,000 shares at $0 per share on Aug. 31, 2026. Her reported ownership after the transaction was 2,000 shares.
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) reported net losses of $2.723 million for the three months and $4.633 million for the six months ended June 30, 2026. Basic and diluted net loss per share was $2.81 for the quarter and $5.21 for the six-month period. …
Glucotrack, Inc. (NASDAQ: GCTK) has a reported 9.99% beneficial stake associated with White Lion Capital LLC, representing 79,734 common shares. The position covers securities held directly and potential share acquisitions under several agreements and instruments.